Sensible Drug Policy in the Psychedelic Era Part 2 ft. Dr. Elijah Ullman, Brett Phelps & Robert Rush

Welcome to season 4. In this two part episode, Alaina talks about the ongoing petition against the DEA's proposed rule to schedule DOI and DOC. In the first half of this episode, Alaina is joined by Elijah Z. Ullman, of the SSDP Science Policy Committee. They discuss the background and specific reasons why DOI and DOC should not be scheduled. In the second half of the podcast, Alaina is joined by Brett Phelps and Robert Rush, the legal counsel representing two of the three parties involved in the DEA case. For more information on SSDP visit: https://ssdp.org/For more information on our lawyers:https://rrushlaw.com/about/https://brettphelpslaw.com/Suggested reading on the topic:https://www.marijuanamoment.net/deas-move-to-ban-two-psychedelics-is-challenged-as-a-disservice-to-science-in-legal-filing-from-student-group/https://filtermag.org/block-dea-psychedelics-ban/https://www.aspet.org/docs/default-source/advocacy-files/aspet-dea-doi-and-doc-comments-1-12-2024.pdf?sfvrsn=62e172d3_0https://www.nature.com/articles/nrn3530Content only reflects opinions of the authors and does not reflect the opinion of others or author affiliations. Support this podcast: https://podcasters.spotify.com/pod/show/psychedelicbrainscience/support

There are no comments yet.

Please log in to write the first comment.